Your browser doesn't support javascript.
loading
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale.
Singer, Susanne; Hammerlid, Eva; Tomaszewska, Iwona M; Amdal, Cecilie Delphin; Bjordal, Kristin; Herlofson, Bente Brokstad; Santos, Marcos; Silva, Joaquim Castro; Mehanna, Hisham; Fullerton, Amy; Brannan, Christine; Gonzalez, Loreto Fernandez; Inhestern, Johanna; Pinto, Monica; Arraras, Juan I; Yarom, Noam; Bonomo, Pierluigi; Baumann, Ingo; Galalae, Razvan; Nicolatou-Galitis, Ourania; Kiyota, Naomi; Raber-Durlacher, Judith; Salem, Dina; Fabian, Alexander; Boehm, Andreas; Krejovic-Trivic, Sanja; Chie, Wei-Chu; Taylor, Katherine; Simon, Christian; Licitra, Lisa; Sherman, Allen C.
Afiliación
  • Singer S; Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Centre of Johannes Gutenberg University, Obere Zahlbacher Straße 69, 55131, Mainz, Germany. singers@uni-mainz.de.
  • Hammerlid E; Department of Otorhinolaryngology-Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy At University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Tomaszewska IM; Department of Medical Didactics, Jagiellonian University Medical College, Krakow, Poland.
  • Amdal CD; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Bjordal K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Herlofson BB; Department of Research Support Services, Oslo University Hospital, Oslo, Norway.
  • Santos M; Department of Oral Surgery and Oral Medicine, University of Oslo, Oslo, Norway.
  • Silva JC; Division for Head, Neck and Reconstructive Surgery, Department of Otorhinolaryngology - Head and Neck Surgery, Oslo University Hospital, Oslo, Norway.
  • Mehanna H; Radiation Oncology Department, Grupo CONFIAR, Goiania, GO, Brazil.
  • Fullerton A; Department of Otolaryngology, Head and Neck Surgery, Instituto Português de Oncologia Francisco Gentil Do Porto, Porto, Portugal.
  • Brannan C; Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK.
  • Gonzalez LF; Department of Communication Sciences and Disorders, Brooks Rehabilitation College of Healthcare Sciences, Jacksonville University, Jacksonville, FL, USA.
  • Inhestern J; Lynda Jackson Macmillan Centre, East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, UK.
  • Pinto M; Instituto Oncologico Fundación Arturo Lopez Perez, Santiago, Chile.
  • Arraras JI; Department of Otorhinolaryngology, Oberhavelkliniken, Hennigsdorf, Germany.
  • Yarom N; Strategic Health Services Department, Istituto Nazionale Tumori -IRCCS- Fondazione G. Pascale, Napoli, Italy.
  • Bonomo P; Oncology Departments, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Baumann I; Oral Medicine Unit, Sheba Medical Center, Tel-Hashomer, Israel.
  • Galalae R; School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nicolatou-Galitis O; Radiation Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Kiyota N; Department of Otolaryngology, Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany.
  • Raber-Durlacher J; MedAustron, Vienna, Austria.
  • Salem D; Dental Oncology Unit, Clinic of Hospital Dentistry, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.
  • Fabian A; Department of Medical Oncology and Hematology, Kobe University Hospital Cancer Center, Kobe, Japan.
  • Boehm A; Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Krejovic-Trivic S; Department of Oral Medicine ACTA, University of Amsterdam and Vrije Universiteit, Amsterdam, The Netherlands.
  • Chie WC; Department of Medical Oncology, Ain Shams-University, Cairo, Egypt.
  • Taylor K; Department of Radiation Therapy, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Simon C; Department of Otolaryngology Head and Neck Surgery, St. Georg Hospital, Leipzig, Germany.
  • Licitra L; Clinic of Otorhinolaryngology and Maxillofacial Surgery, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Sherman AC; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taiwan, Taiwan.
Qual Life Res ; 31(3): 841-853, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34272632
ABSTRACT

PURPOSE:

The aim of this study was to explore what methods should be used to determine the minimal important difference (MID) and minimal important change (MIC) in scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43.

METHODS:

In an international multi-centre study, patients with head and neck cancer completed the EORTC QLQ-HN43 before the onset of treatment (t1), three months after baseline (t2), and six months after baseline (t3). The methods explored for determining the MID were (1) group comparisons based on performance status; (2) 0.5 and 0.3 standard deviation and standard error of the mean. The methods examined for the MIC were patients' subjective change ratings and receiver-operating characteristics (ROC) curves, predictive modelling, standard deviation, and standard error of the mean. The EORTC QLQ-HN43 Swallowing scale was used to investigate these methods.

RESULTS:

From 28 hospitals in 18 countries, 503 patients participated. Correlations with the performance status were |r|< 0.4 in 17 out of 19 scales; hence, performance status was regarded as an unsuitable anchor. The ROC approach yielded an implausible MIC and was also discarded. The remaining approaches worked well and delivered MID values ranging from 10 to 14; the MIC for deterioration ranged from 8 to 16 and the MIC for improvement from - 3 to - 14.

CONCLUSIONS:

For determining MIDs of the remaining scales of the EORTC QLQ-HN43, we will omit comparisons of groups based on the Karnofsky Performance Score. Other external anchors are needed instead. Distribution-based methods worked well and will be applied as a starting strategy for analyses. For the calculation of MICs, subjective change ratings, predictive modelling, and standard-deviation based approaches are suitable methods whereas ROC analyses seem to be inappropriate.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Deglución / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Deglución / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article